Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma

BACKGROUND: Multiple myeloma is a disease of the elderly. However, 40% of patients are diagnosed before 65 years old. Outcomes regarding age as a prognostic factor in MM are heterogeneous. METHOD: We retrospectively analyzed clinical characteristics, response to treatment and survival of 282 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Bove, Virginia, Garrido, David, Riva, Eloisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446251/
https://www.ncbi.nlm.nih.gov/pubmed/32912838
http://dx.doi.org/10.1016/j.htct.2020.06.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446251/
https://www.ncbi.nlm.nih.gov/pubmed/32912838
http://dx.doi.org/10.1016/j.htct.2020.06.014

Ejemplares similares